Stem Cell News

  • 3rd Annual BeSSCR meeting in Hasselt

    Posted on juni 6, 2016

    The BeSSCR Board is proud to invite you to the 3rd annual meeting of the BeSSCR which will be held as a joint meeting together with the European Society of Dental & Craniofacial Stem Cells (ESDCSC) in Hasselt on Friday September 16th, 2016.

    Following keynote speakers have already confirmed their presence; we hope that you will do so too:
    Prof. Dr. Ludovic Vallier – Cambridge Stem Cell Institute
    Prof. Dr. Hans-Reimer Rodewald – Heidelberg University Hospital
    Prof. Dr. Anibal Diogenes – University of Texas Health Science Center
    Prof. Dr. Paul Cooper – The University of Birmingham
    Dr. Valérie Wittamer – Université Libre de Bruxelles
    Prof. Dr. Vincent Pasque – Katholieke Universiteit Leuven
    Prof. Dr. Wen-Hui Lien – Université Catholique de Louvain

    With best regards and looking forward to meeting you in Hasselt!
    The BeSSCR Board

  • Stem Cells as Disease Model and for Gene Therapy

    Posted on februari 22, 2016

    Dear colleagues,

    We kindly invite you to the first joint BeSSCR/BSCDB meeting on the use of stem cells as disease model and for gene therapy, on Friday May 27th in Brussels.

    For this meeting, the Belgian Society for Stem Cell Research and the Belgian Society for Cell and Developmental Biology join forces to present you an attractive program including international renowned speakers and several presentation opportunities for PhDs and Post-Docs.

    On the program:
    Dr. Rachel Eiges – Shaare Zedek Medical Center – Jerusalem, IL “Human pluripotent stem cells as a model for DNA repeat instability”
    Dr Bon-Kyoung Koo – Wellcome Trust – MRC Stem Cell Institute – Cambridge, UK “LGR5+ intestinal stem cells and CFTR gene correction in adult stem cells”
    Dr. Thierry VandenDriessche –Vrije Universiteit Brussel “Stem cell-based gene therapy of Duchenne muscular dystrophy”
    Dr. Peter Ponsaerts – Universiteit Antwerpen “IL13-mediated alternative activation of microglia and macrophages in mouse models of neuroinflammation: genetically engineered stem cells versus lentiviral vector gene therapy”

    Looking forward to meeting you in Brussels!